Swedish startup Halmos Labs joins Y Combinator to build automated biotech R&D
Halmos Labs, a new biotech startup based in Lund in southern Sweden, has joined Y Combinator's fall 2026 batch, and thereby also secured $500K in first funding.
The company is building automated biotech R&D on the principles of validity and interpretabillity, according to its YC profile page. That includes running research and simulations answering open questions ranging from wetlab experiment design to full cancer vaccine manufacturing.
The young founders, Mattias Akke and Linus von Ekensteen Löfgren, hold Master's degrees in Nanotechnology and Engineering Physics, and have previous experience from MIT, AstraZenica, and Danske Bank.
While the company itself is named Halmos Labs, its first product will be called Halmos Bio, founder Mattias Akke tells me.
